A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

Stephen C. Piscitelli, Ana B. Pavel, Kimberly McHale, John E. Jett, Jon Collins, Dawn Gillmor, Glenn Tabolt, Randall Li, Teresa Song, Ning Zhang, Anna M. Tallman, Emma Guttman-Yassky

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish
Pages (from-to)1847-1851
Number of pages5
JournalJournal of Investigative Dermatology
Issue number7
StatePublished - Jul 2021

Cite this